Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritonavir versus raltegravir in healthy adults for postprandial lipid effects
ACTRN12607000622404Phase 4Completed
- Sponsor
- St Vincent's Hospital Sydney
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial comparing Raltegravir arm with Ritonavir arm (2 arms). Primary endpoint: Postprandial triglyceride levels. Started Jun 2008; status: completed.
02
Drugs
ritonavirraltegravir
Beyond the preview
Go deeper on ACTRN12607000622404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000622404.